Multidrug-resistant Neisseria gonorrhoeae isolate SE690: mosaic penA-60.001 gene causing ceftriaxone resistance internationally has spread to the more antimicrobial- susceptible genomic lineage, Sweden, September 2022

被引:16
|
作者
Golparian, Daniel [1 ]
Vestberg, Nora [2 ]
Sodersten, Wiktor [3 ]
Jacobsson, Susanne [1 ]
Ohnishik, Makoto [4 ]
Fang, Hong [2 ]
Bhattarai, Karin Haij [2 ]
Unemo, Magnus [1 ,5 ]
机构
[1] Orebro Univ, Fac Med & Hlth, WHO Collaborating Ctr Gonorrhoea & Other STIs, Natl Reference Lab STI,Dept Lab Med, Orebro, Sweden
[2] Karolinska Univ Hosp, Dept Clin Microbiol, Huddinge, Sweden
[3] Karolinska Univ Hosp, Dept Venerol, Stockholm, Sweden
[4] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan
[5] Univ Coll London UCL, Inst Global Hlth, London, England
关键词
D O I
10.2807/1560-7917.ES.2023.28.10.2300125
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We report a ceftriaxone-resistant, multidrug-resist-ant urogenital Neisseria gonorrhoeae in a female sex worker in Sweden, September 2022, who was treated with ceftriaxone i g, but did not return for test-of-cure. Whole genome sequencing of isolate SE690 identified MLST ST8i30, NG-STAR CCi885 (new NG-STAR ST4859) and mosaic penA-6o.oo1. The latter, causing ceftriax-one resistance in the internationally spreading FC428 clone, has now also spread to the more antimicrobial -susceptible genomic lineage B, showing that strains across the gonococcal phylogeny can develop ceftri-axone resistance.
引用
收藏
页数:6
相关论文
empty
未找到相关数据